"We've partnered with numerous CDMOs over the years, and the Biocina team consistently distinguishes itself through its flexibility, responsiveness, and ability to solve complex manufacturing challenges. Their commitment to delivering high-quality work on aggressive timelines has made them a trusted and invaluable partner throughout our drug development journey."
Kevin Christal
Veola Therapeutics, CEO
"Miist has been very impressed with our partnership with BioCina. The BioCina team truly understood the needs of a start-up medtech/pharma company, showing true partnership support as we moved through drug product development for two programs. BioCina's drug product R&D team displayed nimbleness and flexibiity that is a needed in early stage drug product development when this is running alongside a partner drug delivery device R&D program. There was a clear understanding of our commecial vision to which they were able to use their expertise to add to, and provide guidance on the immediate and future steps to achieve it. It was a true partnership with our success at the forefront of their thinking, led by a great bunch of humans at BioCina."
Dougal Thring
Miist Therapeutics, Head of Pharmaceutical Development
"As OYE-101 advances through clinical development, BioCina has demonstrated a strong commitment to our program. Their dedicated project team, exceptional project management, highly engaged senior leadership, and continued investment in operational expertise have strengthened execution and increased our confidence as we prepare for the next stage of manufacturing on the path to commercialization."
Michael Hicks
OYE Therapeutics, COO
"As a small biotech with no prior experience in drug product manufacture, we relied heavily on Biocina's expertise for both formulation and fill-finish of our drug product. What stood out most was their flexibility and problem-solving mindset. The team at Biocina worked collaboratively with us at every step, translating complex CDMO processes into something manageable for a team new to this space. We'd readily recommend Biocina as a CDMO partner, especially to other small biotechs looking for a hands-on, solutions-oriented team."
Mark Devlin and Geoffrey Matthews
Aculeus Therapeutics, CEO and CSO
"BioCina is a valued manufacturing and development partner for LumaCina. Their team has demonstrated a high level of responsiveness and flexibility, particularly in adapting production schedules to accommodate changing market demand. We have also appreciated their collaborative approach to exploring new development opportunities, with a willingness to work closely alongside our team to identify and support future growth initiatives. Their commitment to this partnership makes them a trusted extension of our business."